Clancy Paul J
Insider CIK 1409601 · EXAS Director · AGIO Director · XLO Director · SION Director · BIIB Executive VP and CFO · INCY Director · ALXN EVP, Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| INCY INCYTE CORP | A Award | 2026-09-30 | 2026-10-02 | 203 | $121.35 | $24.6K | 25,838 | SEC↗ |
| INCY INCYTE CORP | A Award | 2026-06-30 | 2026-07-02 | 252 | $113.36 | $28.6K | 25,635 | SEC↗ |
| SION Sionna Therapeutics, Inc. | A Award deriv | 2026-06-17 | 2026-06-18 | 17,340 | — | $0 | 17,340 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2026-06-08 | 2026-06-10 | 6,111 | — | $0 | 6,111 | SEC↗ |
| INCY INCYTE CORP | A Award | 2026-06-08 | 2026-06-10 | 1,642 | — | $0 | 25,383 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2026-05-19 | 2026-05-21 | 15,000 | — | $0 | 0 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2026-05-19 | 2026-05-21 | 15,000 | $84.53 | $1.27M | 38,741 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2026-05-19 | 2026-05-21 | 15,000 | $94.93 | $1.42M | 23,741 | SEC↗ |
| INCY INCYTE CORP | A Award | 2026-03-31 | 2026-04-02 | 265 | $94.12 | $24.9K | 23,741 | SEC↗ |
| EXAS EXACT SCIENCES CORP | D To issuer | 2026-03-23 | 2026-03-23 | 5,398 | — | $0 | 0 | SEC↗ |
| EXAS EXACT SCIENCES CORP | D To issuer | 2026-03-23 | 2026-03-23 | 20,640 | — | $0 | 5,398 | SEC↗ |
| INCY INCYTE CORP | A Award | 2025-12-31 | 2026-01-05 | 241 | $98.77 | $23.8K | 23,476 | SEC↗ |
| INCY INCYTE CORP | A Award | 2025-09-30 | 2025-10-02 | 285 | $84.81 | $24.2K | 23,235 | SEC↗ |
| INCY INCYTE CORP | A Award | 2025-06-30 | 2025-07-02 | 361 | $68.10 | $24.6K | 22,950 | SEC↗ |
| SION Sionna Therapeutics, Inc. | A Award deriv | 2025-06-12 | 2025-06-16 | 19,959 | — | $0 | 19,959 | SEC↗ |
| EXAS EXACT SCIENCES CORP | A Award | 2025-06-12 | 2025-06-16 | 5,398 | — | $0 | 26,038 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | A Award deriv | 2025-06-11 | 2025-06-12 | 31,000 | — | $0 | 31,000 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2025-06-10 | 2025-06-12 | 9,216 | — | $0 | 9,216 | SEC↗ |
| INCY INCYTE CORP | A Award | 2025-06-10 | 2025-06-12 | 2,518 | — | $0 | 22,589 | SEC↗ |
| INCY INCYTE CORP | A Award | 2025-03-31 | 2025-04-02 | 358 | $60.55 | $21.7K | 20,071 | SEC↗ |
| INCY INCYTE CORP | A Award | 2024-12-31 | 2025-01-03 | 331 | $69.07 | $22.9K | 19,713 | SEC↗ |
| INCY INCYTE CORP | A Award | 2024-09-30 | 2024-10-02 | 368 | $66.10 | $24.3K | 19,382 | SEC↗ |
| INCY INCYTE CORP | A Award | 2024-06-28 | 2024-07-02 | 399 | $60.62 | $24.2K | 19,014 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | A Award deriv | 2024-06-14 | 2024-06-17 | 25,000 | — | $0 | 25,000 | SEC↗ |
| EXAS EXACT SCIENCES CORP | A Award | 2024-06-13 | 2024-12-20 | 5,939 | — | $0 | 20,640 | SEC↗ |
| EXAS EXACT SCIENCES CORP | A Award | 2024-06-13 | 2024-06-17 | 5,444 | — | $0 | 20,145 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2024-06-12 | 2024-06-14 | 12,517 | — | $0 | 12,517 | SEC↗ |
| INCY INCYTE CORP | A Award | 2024-06-12 | 2024-06-14 | 2,830 | — | $0 | 18,615 | SEC↗ |
| INCY INCYTE CORP | A Award | 2024-03-28 | 2024-04-02 | 403 | $56.97 | $23.0K | 15,785 | SEC↗ |
| INCY INCYTE CORP | A Award | 2023-12-29 | 2024-01-03 | 412 | $62.79 | $25.9K | 15,382 | SEC↗ |
| INCY INCYTE CORP | A Award | 2023-09-29 | 2023-10-03 | 379 | $57.77 | $21.9K | 14,970 | SEC↗ |
| INCY INCYTE CORP | A Award | 2023-06-30 | 2023-07-05 | 380 | $62.25 | $23.7K | 14,591 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2023-06-14 | 2023-06-16 | 11,294 | — | $0 | 11,294 | SEC↗ |
| INCY INCYTE CORP | A Award | 2023-06-14 | 2023-06-16 | 2,505 | — | $0 | 14,211 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | A Award deriv | 2023-06-12 | 2023-06-13 | 13,200 | — | $0 | 13,200 | SEC↗ |
| EXAS EXACT SCIENCES CORP | A Award | 2023-06-08 | 2023-06-12 | 3,599 | — | $0 | 14,701 | SEC↗ |
| INCY INCYTE CORP | A Award | 2023-03-31 | 2023-04-04 | 318 | $72.27 | $23.0K | 11,706 | SEC↗ |
| INCY INCYTE CORP | A Award | 2022-12-30 | 2023-01-04 | 294 | $80.32 | $23.6K | 11,388 | SEC↗ |
| INCY INCYTE CORP | A Award | 2022-09-30 | 2022-10-04 | 339 | $66.64 | $22.6K | 11,094 | SEC↗ |
| INCY INCYTE CORP | A Award | 2022-06-30 | 2022-07-01 | 321 | $75.97 | $24.4K | 10,755 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2022-06-21 | 2022-06-23 | 4,975 | — | $0 | 4,975 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2022-06-21 | 2022-06-23 | 29,307 | — | $0 | 29,307 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2022-06-15 | 2022-06-17 | 9,124 | — | $0 | 9,124 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | A Award deriv | 2022-06-15 | 2022-06-17 | 13,200 | — | $0 | 13,200 | SEC↗ |
| INCY INCYTE CORP | A Award | 2022-06-15 | 2022-06-17 | 2,144 | — | $0 | 10,434 | SEC↗ |
| EXAS EXACT SCIENCES CORP | A Award | 2022-06-09 | 2022-06-13 | 5,606 | — | $0 | 11,102 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2022-05-20 | 2022-05-24 | 1,585 | — | $0 | 0 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise | 2022-05-20 | 2022-05-24 | 1,585 | — | $0 | 6,549 | SEC↗ |
| INCY INCYTE CORP | A Award | 2022-03-31 | 2022-04-04 | 326 | $79.42 | $25.9K | 8,290 | SEC↗ |
| INCY INCYTE CORP | A Award | 2021-12-31 | 2022-01-04 | 343 | $73.40 | $25.2K | 7,964 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | A Award deriv | 2021-10-26 | 2021-10-26 | 44,033 | — | $0 | 44,033 | SEC↗ |
| XLO Xilio Therapeutics, Inc. | A Award deriv | 2021-10-26 | 2021-10-26 | 65,528 | — | $0 | 65,528 | SEC↗ |
| INCY INCYTE CORP | A Award | 2021-09-30 | 2021-10-04 | 321 | $68.78 | $22.1K | 7,621 | SEC↗ |
| INCY INCYTE CORP | A Award | 2021-06-30 | 2021-07-02 | 283 | $84.13 | $23.8K | 7,300 | SEC↗ |
| EXAS EXACT SCIENCES CORP | A Award | 2021-06-30 | 2021-07-02 | 2,567 | — | $0 | 5,496 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2021-05-28 | 2021-06-02 | 1,686 | — | $0 | 0 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise | 2021-05-28 | 2021-06-02 | 1,686 | — | $0 | 4,964 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2021-05-26 | 2021-05-28 | 8,010 | — | $0 | 8,010 | SEC↗ |
| INCY INCYTE CORP | A Award | 2021-05-26 | 2021-05-28 | 1,923 | — | $0 | 7,017 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2021-05-20 | 2021-05-24 | 1,585 | — | $0 | 1,585 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2021-05-20 | 2021-05-24 | 8,888 | — | $0 | 8,888 | SEC↗ |
| INCY INCYTE CORP | A Award | 2021-03-31 | 2021-04-01 | 298 | $81.27 | $24.2K | 5,094 | SEC↗ |
| EXAS EXACT SCIENCES CORP | A Award | 2021-03-18 | 2021-03-19 | 2,929 | — | $0 | 2,929 | SEC↗ |
| INCY INCYTE CORP | A Award | 2020-12-31 | 2021-01-05 | 281 | $86.98 | $24.4K | 4,796 | SEC↗ |
| INCY INCYTE CORP | A Award | 2020-09-30 | 2020-10-01 | 260 | $89.74 | $23.3K | 4,515 | SEC↗ |
| INCY INCYTE CORP | A Award | 2020-06-30 | 2020-07-01 | 229 | $103.97 | $23.8K | 4,255 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2020-05-29 | 2020-06-01 | 1,878 | — | $0 | 0 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise | 2020-05-29 | 2020-06-01 | 1,878 | — | $0 | 3,278 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2020-05-28 | 2020-06-01 | 8,096 | — | $0 | 8,096 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2020-05-28 | 2020-06-01 | 1,686 | — | $0 | 1,686 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2020-05-26 | 2020-05-28 | 10,514 | — | $0 | 10,514 | SEC↗ |
| INCY INCYTE CORP | A Award | 2020-05-26 | 2020-05-28 | 1,282 | — | $0 | 4,026 | SEC↗ |
| INCY INCYTE CORP | A Award | 2020-03-31 | 2020-04-02 | 287 | $73.23 | $21.0K | 2,744 | SEC↗ |
| INCY INCYTE CORP | A Award | 2019-12-31 | 2020-01-03 | 231 | $87.32 | $20.2K | 2,457 | SEC↗ |
| INCY INCYTE CORP | A Award | 2019-09-30 | 2019-10-02 | 266 | $74.23 | $19.7K | 2,226 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS, I | F Tax w/h | 2019-07-11 | 2019-07-15 | 5,230 | $124.20 | $649.6K | 90,447 | SEC↗ |
| INCY INCYTE CORP | A Award | 2019-06-28 | 2019-07-02 | 237 | $84.96 | $20.1K | 1,960 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | M Exercise deriv | 2019-05-31 | 2019-05-31 | 1,400 | — | $0 | 0 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | M Exercise | 2019-05-31 | 2019-05-31 | 1,400 | — | $0 | 1,400 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | A Award deriv | 2019-05-29 | 2019-05-31 | 8,919 | — | $0 | 8,919 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | A Award deriv | 2019-05-29 | 2019-05-31 | 1,878 | — | $0 | 1,878 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2019-04-26 | 2019-04-29 | 12,472 | — | $0 | 12,472 | SEC↗ |
| INCY INCYTE CORP | A Award | 2019-04-26 | 2019-04-29 | 1,520 | — | $0 | 1,723 | SEC↗ |
| INCY INCYTE CORP | A Award | 2019-03-29 | 2019-04-02 | 203 | $86.01 | $17.5K | 203 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS, I | F Tax w/h | 2019-02-28 | 2019-03-04 | 1,079 | $132.93 | $143.4K | 86,249 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS, I | A Award | 2019-02-28 | 2019-03-05 | 9,428 | — | $0 | 95,677 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS, I | F Tax w/h | 2019-02-07 | 2019-02-11 | 5,981 | $119.57 | $715.1K | 87,328 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS, I | S Sale | 2018-07-10 | 2018-07-12 | 5,241 | $131.11 | $687.1K | 93,309 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | A Award deriv | 2018-05-31 | 2018-06-04 | 1,400 | — | $0 | 1,400 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | A Award deriv | 2018-05-31 | 2018-06-04 | 5,700 | — | $0 | 5,700 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2018-05-01 | 2018-05-03 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2018-02-28 | 2018-03-02 | 9,536 | — | $0 | 98,550 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2018-02-08 | 2018-02-08 | 6,079 | $116.31 | $707.0K | 89,014 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2018-02-06 | 2018-02-08 | 48,228 | — | $0 | 95,093 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award deriv | 2017-07-10 | 2017-07-12 | 29,089 | — | $0 | 29,089 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2017-07-10 | 2017-07-12 | 46,865 | — | $0 | 46,865 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | A Award deriv | 2017-06-13 | 2017-06-15 | 9,000 | — | $0 | 9,000 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2017-05-26 | 2017-05-31 | 15,000 | — | $0 | 15,000 | SEC↗ |
| BIIB BIOGEN INC. | S Sale | 2017-04-25 | 2017-04-27 | 9,892 | $290.00 | $2.87M | 10,813 | SEC↗ |
| BIIB BIOGEN INC. | S Sale | 2017-03-13 | 2017-03-14 | 9,891 | $291.55 | $2.88M | 20,705 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise deriv | 2017-02-28 | 2017-03-02 | 1,152 | — | $0 | 0 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise deriv | 2017-02-28 | 2017-03-02 | 2,092 | — | $0 | 7,546 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise deriv | 2017-02-28 | 2017-03-02 | 663 | — | $0 | 1,774 | SEC↗ |
| BIIB BIOGEN INC. | J Other deriv | 2017-02-28 | 2017-03-02 | 1,105 | — | $0 | 2,437 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise deriv | 2017-02-28 | 2017-03-02 | 2,873 | — | $0 | 0 | SEC↗ |
| BIIB BIOGEN INC. | J Other deriv | 2017-02-28 | 2017-03-02 | 1,352 | — | $0 | 1,152 | SEC↗ |
| BIIB BIOGEN INC. | J Other deriv | 2017-02-28 | 2017-03-02 | 1,678 | — | $0 | 9,638 | SEC↗ |
| BIIB BIOGEN INC. | F Tax w/h | 2017-02-28 | 2017-03-02 | 312 | $284.75 | $88.8K | 27,221 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise | 2017-02-28 | 2017-03-02 | 663 | — | $0 | 27,533 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise | 2017-02-28 | 2017-03-02 | 2,092 | — | $0 | 29,313 | SEC↗ |
| BIIB BIOGEN INC. | F Tax w/h | 2017-02-28 | 2017-03-02 | 847 | $287.63 | $243.6K | 28,466 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise | 2017-02-28 | 2017-03-02 | 1,152 | — | $0 | 29,618 | SEC↗ |
| BIIB BIOGEN INC. | F Tax w/h | 2017-02-28 | 2017-03-02 | 543 | $274.76 | $149.2K | 29,075 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise | 2017-02-28 | 2017-03-02 | 2,873 | — | $0 | 31,948 | SEC↗ |
| BIIB BIOGEN INC. | F Tax w/h | 2017-02-28 | 2017-03-02 | 1,352 | $274.76 | $371.5K | 30,596 | SEC↗ |
| BIIB BIOGEN INC. | A Award deriv | 2017-02-15 | 2017-02-17 | 7,650 | — | $0 | 7,650 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | A Award deriv | 2016-06-21 | 2016-06-23 | 9,000 | — | $0 | 58,400 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2016-05-27 | 2016-05-31 | 15,000 | — | $0 | 15,000 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise deriv | 2016-02-23 | 2016-02-25 | 579 | — | $0 | 4,611 | SEC↗ |
| BIIB BIOGEN INC. | J Other deriv | 2016-02-23 | 2016-02-25 | 1,149 | — | $0 | 3,462 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise | 2016-02-23 | 2016-02-25 | 579 | — | $0 | 27,143 | SEC↗ |
| BIIB BIOGEN INC. | F Tax w/h | 2016-02-23 | 2016-02-25 | 273 | $258.99 | $70.7K | 26,870 | SEC↗ |
| BIIB BIOGEN INC. | A Award deriv | 2016-02-22 | 2016-02-24 | 11,060 | — | $0 | 11,060 | SEC↗ |
| BIIB BIOGEN INC. | J Other deriv | 2016-02-12 | 2016-02-17 | 1,394 | — | $0 | 2,448 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise deriv | 2016-02-12 | 2016-02-17 | 2,807 | — | $0 | 2,808 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise deriv | 2016-02-12 | 2016-02-17 | 1,052 | — | $0 | 3,842 | SEC↗ |
| BIIB BIOGEN INC. | F Tax w/h | 2016-02-12 | 2016-02-17 | 1,204 | $247.22 | $297.7K | 26,564 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise | 2016-02-12 | 2016-02-17 | 2,807 | — | $0 | 27,768 | SEC↗ |
| BIIB BIOGEN INC. | F Tax w/h | 2016-02-12 | 2016-02-17 | 495 | $247.22 | $122.4K | 24,961 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise | 2016-02-12 | 2016-02-17 | 1,052 | — | $0 | 25,456 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise deriv | 2016-02-08 | 2016-02-09 | 3,194 | — | $0 | 0 | SEC↗ |
| BIIB BIOGEN INC. | F Tax w/h | 2016-02-08 | 2016-02-09 | 1,047 | $250.77 | $262.6K | 24,404 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise | 2016-02-08 | 2016-02-09 | 3,194 | — | $0 | 25,451 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | A Award deriv | 2015-06-23 | 2015-06-25 | 11,900 | — | $0 | 49,400 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2015-05-22 | 2015-05-27 | 15,000 | — | $0 | 15,000 | SEC↗ |
| BIIB BIOGEN IDEC INC. | A Award deriv | 2015-02-23 | 2015-02-25 | 5,190 | — | $0 | 5,190 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2015-02-12 | 2015-02-17 | 1,492 | — | $0 | 5,848 | SEC↗ |
| BIIB BIOGEN IDEC INC. | J Other deriv | 2015-02-12 | 2015-02-17 | 954 | — | $0 | 4,894 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2015-02-12 | 2015-02-17 | 2,807 | — | $0 | 5,615 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2015-02-12 | 2015-02-17 | 1,323 | $392.11 | $518.8K | 21,468 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2015-02-12 | 2015-02-17 | 1,492 | — | $0 | 22,960 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2015-02-12 | 2015-02-17 | 703 | $392.11 | $275.7K | 22,257 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2015-02-12 | 2015-02-17 | 2,807 | — | $0 | 22,791 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2015-02-09 | 2015-02-10 | 4,691 | — | $0 | 0 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2015-02-09 | 2015-02-10 | 4,691 | — | $0 | 22,194 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2015-02-09 | 2015-02-10 | 2,210 | $396.88 | $877.1K | 19,984 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2015-02-08 | 2015-02-10 | 3,191 | — | $0 | 3,194 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2015-02-08 | 2015-02-10 | 3,191 | — | $0 | 18,646 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2015-02-08 | 2015-02-10 | 1,143 | $402.00 | $459.5K | 17,503 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2015-01-20 | 2015-01-22 | 25,000 | — | $0 | 25,000 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2015-01-20 | 2015-01-22 | 5,000 | — | $0 | 5,000 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | A Award deriv | 2014-05-30 | 2014-06-05 | 14,000 | — | $0 | 37,500 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2014-02-23 | 2014-02-25 | 4,280 | — | $0 | 0 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2014-02-23 | 2014-02-25 | 2,018 | $347.11 | $700.5K | 15,455 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2014-02-23 | 2014-02-25 | 4,280 | — | $0 | 17,473 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2014-02-12 | 2014-02-14 | 2,807 | — | $0 | 8,422 | SEC↗ |
| BIIB BIOGEN IDEC INC. | A Award deriv | 2014-02-12 | 2014-02-14 | 7,340 | — | $0 | 7,340 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2014-02-12 | 2014-02-14 | 2,807 | — | $0 | 14,517 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2014-02-12 | 2014-02-14 | 1,324 | $323.04 | $427.7K | 13,193 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2014-02-09 | 2014-02-11 | 4,691 | — | $0 | 4,691 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2014-02-09 | 2014-02-11 | 4,691 | — | $0 | 13,922 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2014-02-09 | 2014-02-11 | 2,212 | $315.54 | $698.0K | 11,710 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2014-02-08 | 2014-02-11 | 3,191 | — | $0 | 6,385 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2014-02-08 | 2014-02-11 | 3,191 | — | $0 | 10,278 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2014-02-08 | 2014-02-11 | 1,047 | $315.54 | $330.4K | 9,231 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | A Award deriv | 2013-12-04 | 2013-12-06 | 1,500 | — | $0 | 23,500 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | A Award deriv | 2013-09-24 | 2013-09-26 | 22,000 | — | $0 | 22,000 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2013-09-18 | 2013-09-19 | 26,785 | — | $0 | 0 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-09-18 | 2013-09-19 | 26,785 | $245.00 | $6.56M | 7,087 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2013-09-18 | 2013-09-19 | 26,785 | $49.65 | $1.33M | 33,872 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2013-09-16 | 2013-09-18 | 43,940 | — | $0 | 0 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2013-09-16 | 2013-09-18 | 10,990 | — | $0 | 0 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2013-09-16 | 2013-09-18 | 6,000 | — | $0 | 0 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2013-09-16 | 2013-09-18 | 20,000 | — | $0 | 0 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2013-09-16 | 2013-09-18 | 18,100 | — | $0 | 0 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-09-16 | 2013-09-18 | 1,800 | $239.84 | $431.7K | 7,087 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-09-16 | 2013-09-18 | 1,525 | $239.00 | $364.5K | 8,887 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-09-16 | 2013-09-18 | 5,165 | $238.12 | $1.23M | 10,412 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-09-16 | 2013-09-18 | 2,500 | $237.05 | $592.6K | 15,577 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2013-09-16 | 2013-09-18 | 10,990 | $44.24 | $486.2K | 18,077 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-09-16 | 2013-09-18 | 9,098 | $239.75 | $2.18M | 7,087 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-09-16 | 2013-09-18 | 11,134 | $238.56 | $2.66M | 16,185 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-09-16 | 2013-09-18 | 14,708 | $237.93 | $3.50M | 27,319 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-09-16 | 2013-09-18 | 9,000 | $236.94 | $2.13M | 42,027 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2013-09-16 | 2013-09-18 | 43,940 | $60.56 | $2.66M | 51,027 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-09-16 | 2013-09-18 | 3,970 | $239.76 | $951.8K | 7,087 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-09-16 | 2013-09-18 | 4,300 | $238.65 | $1.03M | 11,057 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-09-16 | 2013-09-18 | 7,503 | $238.00 | $1.79M | 15,357 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-09-16 | 2013-09-18 | 4,227 | $236.99 | $1.00M | 22,860 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2013-09-16 | 2013-09-18 | 20,000 | $63.55 | $1.27M | 27,087 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-09-16 | 2013-09-18 | 3,210 | $239.79 | $769.7K | 7,087 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-09-16 | 2013-09-18 | 3,269 | $238.80 | $780.6K | 10,297 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-09-16 | 2013-09-18 | 7,221 | $238.12 | $1.72M | 13,566 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-09-16 | 2013-09-18 | 4,400 | $237.05 | $1.04M | 20,787 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2013-09-16 | 2013-09-18 | 18,100 | $49.31 | $892.5K | 25,187 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-09-16 | 2013-09-18 | 100 | $240.20 | $24.0K | 7,087 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-09-16 | 2013-09-18 | 1,475 | $239.54 | $353.3K | 7,187 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2013-09-16 | 2013-09-18 | 6,000 | $41.03 | $246.2K | 13,087 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-09-16 | 2013-09-18 | 1,600 | $237.05 | $379.3K | 11,487 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-09-16 | 2013-09-18 | 2,825 | $238.29 | $673.2K | 8,662 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-04-30 | 2013-05-01 | 900 | $226.01 | $203.4K | 7,087 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-04-30 | 2013-05-01 | 6,241 | $225.40 | $1.41M | 7,987 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-04-30 | 2013-05-01 | 5,380 | $224.34 | $1.21M | 14,228 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-04-30 | 2013-05-01 | 1,968 | $222.57 | $438.0K | 19,608 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-04-29 | 2013-05-01 | 9,123 | $219.71 | $2.00M | 21,576 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2013-02-23 | 2013-02-26 | 4,281 | — | $0 | 4,280 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2013-02-23 | 2013-02-26 | 2,021 | $164.40 | $332.3K | 30,699 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2013-02-23 | 2013-02-26 | 4,281 | — | $0 | 32,720 | SEC↗ |
| BIIB BIOGEN IDEC INC. | A Award deriv | 2013-02-12 | 2013-02-14 | 11,229 | — | $0 | 11,229 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2013-02-09 | 2013-02-12 | 4,692 | — | $0 | 9,382 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2013-02-09 | 2013-02-12 | 4,692 | — | $0 | 30,170 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2013-02-09 | 2013-02-12 | 1,731 | $164.44 | $284.6K | 28,439 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2013-02-08 | 2013-02-12 | 2,765 | — | $0 | 10,002 | SEC↗ |
| BIIB BIOGEN IDEC INC. | J Other deriv | 2013-02-08 | 2013-02-12 | 426 | — | $0 | 9,576 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2013-02-08 | 2013-02-12 | 899 | $164.44 | $147.8K | 25,478 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2013-02-08 | 2013-02-12 | 2,765 | — | $0 | 26,377 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2012-02-24 | 2012-02-27 | 1,386 | $116.39 | $161.3K | 25,012 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2012-02-24 | 2012-02-27 | 1,400 | $116.39 | $162.9K | 23,612 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2012-02-23 | 2012-02-27 | 4,281 | — | $0 | 8,561 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2012-02-23 | 2012-02-27 | 1,786 | $116.70 | $208.4K | 26,398 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2012-02-23 | 2012-02-27 | 4,281 | — | $0 | 28,184 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2012-02-09 | 2012-02-13 | 4,692 | — | $0 | 14,074 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2012-02-09 | 2012-02-13 | 4,692 | — | $0 | 25,860 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2012-02-09 | 2012-02-13 | 1,957 | $117.78 | $230.5K | 23,903 | SEC↗ |
| BIIB BIOGEN IDEC INC. | A Award deriv | 2012-02-08 | 2012-02-10 | 12,767 | — | $0 | 12,767 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2012-02-01 | 2012-02-03 | 8,400 | — | $0 | 0 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2012-02-01 | 2012-02-03 | 13,000 | — | $0 | 0 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2012-02-01 | 2012-02-03 | 8,400 | $67.57 | $567.6K | 42,568 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2012-02-01 | 2012-02-03 | 13,000 | $43.50 | $565.5K | 34,168 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2012-02-01 | 2012-02-03 | 13,000 | $120.00 | $1.56M | 29,568 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2012-02-01 | 2012-02-03 | 8,400 | $120.00 | $1.01M | 21,168 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2012-01-03 | 2012-01-04 | 14,670 | $112.22 | $1.65M | 26,742 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2012-01-03 | 2012-01-04 | 5,574 | $112.69 | $628.1K | 21,168 | SEC↗ |